End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 CNY | -3.55% |
|
-4.39% | -53.72% |
06-26 | Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology | MT |
06-18 | Walvax Terminates Coronavirus Vaccine Trials Due to Mutations | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.72% | 2.39B | |
+4.57% | 96.72B | |
+5.66% | 41.43B | |
-13.20% | 32.7B | |
+82.00% | 29.06B | |
-16.02% | 15.38B | |
-8.17% | 12.97B | |
-13.35% | 11.36B | |
+160.91% | 9.9B | |
-56.29% | 8.79B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Terminates Coronavirus Vaccine Trials Due to Mutations